Tolcapone

Indication

Tolcapone as an adjunct to co-beneldopa or co-careldopa in Parkinson's disease with 'end-of-dose' motor fluctuations if another inhibitor of peripheral catechol-O-methyltransferase is inappropriate

Red

Brand:

Tasmar

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

BNF chapter:

Central nervous system

Background

Tolcapone to be used as a third-line COMT inhibitor

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Pending

What do the colours mean?

Last Updated: 14 - Oct - 2014

Breadcrumb

Tolcapone

Indication

Background

Recommendation

Decisions of Lancashire local decision making groups